Today: 17 May 2026
Sandisk stock price steadies after Citron short call; Bernstein talk looms for SNDK
25 February 2026
2 mins read

Sandisk stock price steadies after Citron short call; Bernstein talk looms for SNDK

New York, Feb 25, 2026, 10:04 a.m. EST — Regular session

  • Sandisk shares picked up slightly in early trading Wednesday, following a steep, high-volume drop the session before.
  • Citron Research is out with a new short call, grabbing traders’ focus, while some are also watching a Bernstein forum scheduled for later in the day for any signals on flash-memory supply.
  • CEO David Goeckeler recently offloaded shares, according to a filing, with the transactions linked to tax withholding.

Sandisk (SNDK.O) edged up roughly 0.2% to $639.76 in early Wednesday action, recovering some ground after a whipsaw drop reignited interest in the flash-memory name. The Nasdaq gained 1.1%. Storage rivals Western Digital and Seagate ticked higher as well.

SanDisk shares slumped Tuesday after Citron Research went public with a fresh short position, warning of cyclical headwinds in memory and ramped-up competition. Citron contended the market had it wrong, saying, “NVIDIA has a moat. SanDisk sells a commodity.” Investing.com

Here’s why it’s grabbing attention now: Sandisk is set to appear Wednesday at Bernstein’s “What’s Next in Tech?” event, and investors are watching closely for any word on supply and pricing. KC Rajkumar of Lynx Equity Strategies says he’s looking for management to address the ongoing NAND flash shortage—NAND being the memory behind solid-state drives—and lay out any discussions with major cloud customers about non-cancellable, multi-year supply deals. Investing.com UK

Shares finished Tuesday at $638.52, dropping 4.2% after ranging from $612.92 to $684.09. Volume picked up to roughly 30.4 million shares as the short call landed—well above what’s been typical lately.

Another headache: excess supply—this time, it’s shares, not semiconductors. Western Digital (WDC.O) last week outlined plans to generate $3.17 billion by offloading part of its Sandisk holding, trading 5.8 million shares to address debt, with the remainder set for disposal down the line.

According to the prospectus supplement, selling stockholders are putting the shares up for sale, while Sandisk itself “will not receive any of the proceeds.” This underscores the deal’s real focus: shifting ownership, not raising capital for the company. The filing notes that up to 7,513,019 shares held by Western Digital could be resold under this registration. SEC

Sandisk chief David Goeckeler disclosed in a separate filing that he parted with 1,300 shares on Feb. 20, and another 1,032 shares the following day, both at $649.97. The transactions, flagged as tax-related withholding, were described in the form as “Payment of tax obligation by withholding securities” triggered by vesting. SEC

Yet things can shift in a hurry. Memory markets run in cycles, and just a hint of supply rebounding ahead of schedule—or a crack in pricing strength—can sour sentiment. If shorts pile in and major holders start offloading shares, that packed trade may unravel faster than many expect.

Next up for investors: all eyes on Sandisk’s slot at Bernstein, scheduled for Wednesday at 6:30 p.m. ET. The focus is clear—details on those “multi-year” contracts. Investors want specifics: volumes, pricing, how long these deals really last. They’re also looking for any hint from management about possible short-term softness in datacenter storage demand.

Stock Market Today

  • Aquestive Therapeutics Reports Strong Q1 Results, Analysts Maintain 2026 Forecasts
    May 16, 2026, 8:17 PM EDT. Aquestive Therapeutics (NASDAQ:AQST) posted strong first-quarter results with revenues of $14 million, surpassing analyst expectations by 33%, and smaller-than-expected losses of $0.07 per share. Despite the upbeat quarter, analysts forecast a 3.6% revenue decline in 2026 to $48.4 million and a 15% decrease in losses to $0.47 per share. The consensus price target remains steady at $8.89, suggesting the stock is trading in line with expectations amid continuing losses. Revenue growth is expected to slow significantly compared to the past five years, lagging behind an 8% annual growth forecast for the wider industry. Investors face mixed views on valuation, with targets ranging from $6.00 to $11.00 per share.

Latest articles

Joby Aviation Slides Monday With Air-Taxi in Focus

Joby Aviation Slides Monday With Air-Taxi in Focus

17 May 2026
Joby Aviation shares closed Friday at $10.36, down 2.6% for the day and 4.7% for the week. CEO JoeBen Bevirt-linked trusts sold over 421,000 shares under a preset 10b5-1 plan, filings showed. The stock traded between $10.04 and $10.58 during a volatile week. Broader markets and eVTOL sector peers also declined.
ImmunityBio’s BCG Agreement Puts Monday’s Trading in Focus

ImmunityBio’s BCG Agreement Puts Monday’s Trading in Focus

17 May 2026
ImmunityBio closed at $7.97 Friday, down 2.2% after announcing exclusive U.S. rights to Japan BCG Laboratory’s Tokyo-172 strain for bladder cancer therapy. The Tokyo strain remains investigational in the U.S. and is not FDA-approved. Nasdaq was closed for the weekend; the next trading session is Monday. ImmunityBio’s Q1 product revenue rose to $44.2 million with $380.9 million in cash and securities.
Infleqtion Stock Just Took a Hit After Record Revenue — What Could Move INFQ Next

Infleqtion Stock Just Took a Hit After Record Revenue — What Could Move INFQ Next

17 May 2026
Infleqtion Inc. shares fell 10.95% to $12.44 Friday, capping a rough week for quantum tech stocks. The company reported a first-quarter net loss of $30.3 million on $9.5 million in revenue, with 85% from government contracts. Infleqtion launched a new RF sensing platform and raised its 2026 revenue outlook, but warned of continued operating losses.
Synopsys Shares Dropped for the Week, Looking to May 27 for Direction

Synopsys Shares Dropped for the Week, Looking to May 27 for Direction

17 May 2026
Synopsys shares fell 1.49% Friday to $502.42, ending the week down 2.72% amid a broad tech selloff and news that Coatue Management cut its stake by 54%. The Nasdaq Composite dropped 1.54% Friday, while the Philadelphia semiconductor index slid 4%. Synopsys will report fiscal Q2 results after the market closes on May 27. Wells Fargo and Citigroup raised their price targets for the stock earlier in the week.
Tesla (TSLA) stock price climbs ahead of Nvidia earnings as Autopilot lawsuits return to focus
Previous Story

Tesla (TSLA) stock price climbs ahead of Nvidia earnings as Autopilot lawsuits return to focus

Accenture stock price sinks to new 52-week low as OpenAI tie-up, deals fail to steady ACN shares
Next Story

Accenture stock price sinks to new 52-week low as OpenAI tie-up, deals fail to steady ACN shares

Go toTop